Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atossa Genetics Inc (ATOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,532
  • Shares Outstanding, K 5,647
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,120 K
  • 36-Month Beta 3.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.65
  • Number of Estimates 1
  • High Estimate -0.65
  • Low Estimate -0.65
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.29 +11.63%
on 02/01/19
1.95 -26.15%
on 02/07/19
+0.10 (+7.46%)
since 01/18/19
3-Month
0.80 +80.00%
on 12/26/18
1.95 -26.15%
on 02/07/19
+0.24 (+20.00%)
since 11/21/18
52-Week
0.80 +80.00%
on 12/26/18
9.96 -85.54%
on 03/08/18
-5.64 (-79.66%)
since 02/21/18

Most Recent Stories

More News
Atossa Genetics Reports Results From "Expanded Access" Program for a U.S. Breast Cancer Patient Taking Oral Endoxifen: Sizeable Reduction in Cancer Cell Biological Activity; No Safety or Tolerability Issues

, February 7, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other...

ATOS : 1.44 (-4.64%)
Atossa Genetics Provides Breast Cancer Prevention Recommendations to the United States Preventative Services Task Force

Atossa Genetics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced that...

ATOS : 1.44 (-4.64%)
Atossa Genetics President and CEO Dr. Steven C. Quay Issues Annual Letter to Shareholders Highlighting Key Accomplishments and Strategy for 2019

Atossa Genetics Inc. (Nasdaq:ATOS) today issued the following letter from Dr. Steven C. Quay, President and CEO, to Atossa shareholders:

ATOS : 1.44 (-4.64%)
Thinking about buying stock in American Airlines, Aurora Cannabis Inc, Atossa Genetics, Chesapeake Energy or Tilray?

InvestorsObserver issues critical PriceWatch Alerts for AAL, ACB, ATOS, CHK, and TLRY.

CHK : 2.60 (-5.45%)
ATOS : 1.44 (-4.64%)
AAL : 34.98 (-0.23%)
Today's Research Reports on Trending Tickers: BioTelemetry and Atossa Genetics

NEW YORK, NY / ACCESSWIRE / January 10, 2019 / U.S. markets rose for the fourth consecutive session on Wednesday as minutes released from the Federal Reserve's meeting in December showed the Fed would...

ATOS : 1.44 (-4.64%)
BEAT : 73.34 (-2.71%)
4 Healthcare Stocks Looking To Set January Highs

CORAL GABLES, FL/ ACCESSWIRE / January 9, 2019 / The is predicated on the notion that as diseases become more advanced and difficult to treat, companies responsible for creating treatment options will...

ATOS : 1.44 (-4.64%)
ACST : 0.94 (-1.05%)
VSTM : 3.18 (+1.60%)
Atossa Genetics Announces Successful Completion and Final Results from Male Phase 1 Study of Topical Endoxifen

Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, reported final results from...

ATOS : 1.44 (-4.64%)
Detailed Research: Economic Perspectives on American Airlines Group, Sandstorm Gold, Kala Pharmaceuticals, Adecoagro S.A, Novagold Resources, and Atossa Genetics -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of American Airlines Group Inc....

SAND : 5.78 (+2.85%)
KALA : 8.53 (+2.90%)
NG : 3.84 (+0.26%)
ATOS : 1.44 (-4.64%)
AAL : 34.98 (-0.23%)
AGRO : 7.21 (-2.17%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 23.41 (-1.06%)
NGVC : 14.36 (-1.71%)
STC : 42.39 (-0.93%)
ATUS : 21.03 (-0.85%)
RBA : 36.52 (-0.19%)
MHK : 140.03 (+0.19%)
NVCR : 53.38 (+0.32%)
CVSI : 4.8305 (-2.41%)
AC : 41.73 (-0.26%)
BSX : 40.12 (+0.02%)
HON : 152.61 (-1.27%)
POTND : 0.0200 (+32.45%)
PRTT : 1.0000 (-20.00%)
TARSD : 0.2033 (-1.64%)
NKE : 83.95 (-1.05%)
ROIC : 17.25 (-0.06%)
DGX : 87.81 (-1.27%)
EIX : 61.26 (-2.27%)
GARLF : 0.0794 (-3.99%)
MRNA : 19.34 (-2.91%)
MSPC : 0.0002 (unch)
RYAAY : 73.36 (+0.22%)
BA : 417.58 (-0.94%)
BDC : 60.34 (-5.38%)
BC : 52.10 (-0.36%)
OXFD : 16.87 (-2.60%)
NDAQ : 88.07 (-0.01%)
TTOO : 3.72 (+0.27%)
DMAC : 3.52 (-2.76%)
CMCM : 7.18 (+0.14%)
ALGN : 250.23 (-1.40%)
ABM : 36.68 (-0.11%)
RTN : 185.38 (-1.02%)
IESC : 18.99 (+1.55%)
KIDS : 38.34 (+0.71%)
CYL.VN : 0.165 (+3.13%)
FLIR : 52.25 (-1.04%)
NETC.CN : 0.110 (+4.76%)
SLCA : 15.32 (-3.95%)
BANX : 21.25 (+0.85%)
APOG : 37.10 (+0.41%)
RBBN : 5.36 (-11.70%)
SPLIF : 0.2240 (+0.86%)
SO : 50.22 (+0.97%)
SNWV : 0.1744 (+2.71%)
ACB : 7.06 (-0.14%)
CE : 102.50 (-0.21%)
QILFF : 0.1850 (+1.04%)
QILFD : 0.2331 (-29.98%)
MANH : 54.04 (-0.93%)
MKL : 1,010.40 (-0.92%)
HAL : 31.38 (-2.82%)
LZB : 35.79 (-0.61%)
INTC : 51.41 (+0.04%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,619.44 (-0.16%)
ACHC : 27.72 (+0.65%)
TX : 29.85 (+0.88%)
SRPT : 136.54 (-2.87%)
JOUT : 66.87 (+1.89%)
CCAN : 0.2500 (-3.47%)
OBMP : 0.0100 (+4.17%)
ELY : 16.91 (-0.88%)
DY : 62.62 (-1.65%)
HIPH : 0.0535 (+0.19%)
POTN : 0.1598 (-6.33%)
JWN : 44.49 (-1.13%)
SYF : 31.78 (-0.03%)
AQUA : 12.90 (-1.07%)
NWVCF : 1.2700 (-1.50%)
USYNF : 2.5745 (-18.27%)
EMR : 67.74 (-1.22%)
BXE : 0.46 (-3.16%)
HSY : 111.20 (+0.47%)
EW : 173.94 (-1.55%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 14.40 (+1.05%)
PSX : 96.81 (-0.66%)
MVIS : 1.18 (+2.61%)
PCI : 22.97 (+0.13%)
PCN : 16.47 (+0.49%)
AVT : 44.75 (-0.40%)
MGNX : 21.88 (-1.57%)
ICBK : 19.10 (+0.53%)
DLR : 116.37 (-1.79%)
RHI : 67.39 (-0.50%)
YVR : 2.26 (+7.11%)
PTY : 16.80 (+0.18%)
PDI : 31.26 (+0.19%)
TNXP : 1.96 (unch)
GBT : 50.00 (-1.09%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 85.84 (-0.38%)
NKTR : 40.26 (-6.44%)
GOOG : 1,096.97 (-1.51%)
JBLU : 17.49 (-0.40%)
IGC : 2.49 (unch)
WBT : 15.85 (-1.37%)
WRY.VN : 0.100 (+66.67%)
SAPIF : 31.5581 (+1.42%)
WSO : 142.92 (-0.11%)
LMT : 304.51 (-0.88%)
CMCSA : 38.47 (+1.80%)
HSDT : 7.40 (+0.14%)
GWRE : 91.04 (-0.68%)
CLGX : 39.89 (-0.35%)
FNSR : 23.93 (-0.04%)
SONS : 7.83 (+2.76%)
DEWM : 0.0011 (unch)
SLG : 91.49 (+0.68%)
UPS : 111.76 (+0.62%)
PFN : 10.21 (-0.68%)
KMB : 119.73 (+0.97%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.09 (-0.91%)
NSU : 4.53 (-0.22%)
CBDS : 3.1400 (-1.57%)
CTXS : 104.99 (-0.36%)
PCOM : 10.89 (+0.65%)
HTHT : 34.34 (-2.94%)
MAN : 84.61 (+0.08%)
CNK : 36.90 (-0.70%)
AMAT : 38.83 (-0.44%)
FMCC : 2.7700 (+0.36%)
MRK : 79.83 (+0.50%)
ATOS : 1.44 (-4.64%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0680 (+1.95%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 57.80 (-0.81%)
COOL : 17.33 (-0.69%)
SAVE : 59.58 (+2.71%)
PCRX : 39.61 (-1.59%)
RNLSY : 13.5050 (-0.55%)
COL : 141.04 (-0.42%)
COR : 104.35 (-1.34%)
IDXG : 0.95 (unch)
MCD : 182.81 (+1.29%)
ETST : 0.6730 (-3.86%)
QNIIF : 0.7100 (-2.62%)
PII : 85.95 (-1.06%)
AMRS : 4.63 (+3.58%)
SON : 59.59 (-1.26%)
MCK : 131.95 (-1.56%)
APHA : 10.38 (+2.27%)
MCO : 170.60 (+0.67%)
GSKY : 10.37 (-1.05%)
LH : 148.32 (-0.95%)
SAP.TO : 41.64 (-0.29%)
ODFL : 152.00 (-0.33%)
NEU : 440.71 (+0.90%)
ORTX : 15.61 (-2.25%)
BXE.TO : 0.59 (-4.84%)
GWPRF : 11.7000 (-3.31%)
PZN : 9.70 (+3.41%)
RBX.VN : 0.075 (+7.14%)
RNG : 104.09 (+0.18%)
SPG : 182.15 (+1.63%)
TRVN : 1.39 (-2.11%)
AMC : 13.70 (+0.22%)
UTX : 126.32 (-1.64%)
AMD : 23.92 (-0.13%)
NDLS : 7.45 (+0.95%)
MPWR : 135.29 (-1.00%)
KGKG : 0.0799 (-1.36%)
FRO-UN.VN : 0.520 (-5.45%)
DMCAF : 0.3840 (+0.52%)
IRMTF : 11.9721 (-0.40%)
BOX : 24.29 (+0.54%)
IQST : 2.3800 (+90.40%)
ASPS : 24.09 (-1.03%)
HMNY : 0.0082 (+17.14%)
ROP : 314.80 (+0.42%)
GOVB : 14.0500 (-10.79%)
PKO : 26.18 (-0.04%)
MYGN : 31.70 (-0.88%)
CRL : 142.39 (+0.51%)
GLPH : 0.0151 (-22.16%)
BXXRF : 0.0102 (+100.00%)
ADTN : 14.54 (-0.27%)
GRNH : 0.0187 (+1.63%)
NS : 26.19 (-0.91%)
LTS : 2.99 (-0.99%)
INT : 26.23 (+0.27%)
INPX : 1.45 (-3.33%)
GSPT : 0.0400 (unch)
MRO.VN : 0.090 (unch)
COST : 215.23 (-0.87%)
EFX : 110.49 (+2.18%)
BMRN : 88.81 (-2.04%)
SPGI : 198.15 (+0.07%)
IGCC : 0.3800 (+1.33%)
PYPL : 94.96 (+0.24%)
LHSIF : 0.8840 (+4.68%)
TDY : 233.29 (-1.08%)
AZPN : 99.64 (-0.12%)
ENW.VN : 1.680 (+1.20%)
DMA.VN : 4.630 (-2.11%)
SNAP : 9.39 (+1.62%)
KSU : 111.75 (+0.62%)
MERC : 14.72 (-3.29%)
DVA : 59.21 (+0.25%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.48 (-0.80%)
IGAP : 0.4900 (-19.67%)
FIT : 6.63 (-0.15%)
RAD : 0.75 (-2.60%)
LDSR : 0.0029 (+7.41%)
CYLYF : 0.1253 (+9.05%)
PMX : 12.00 (+0.17%)
ROBXF : 0.1851 (+262.94%)
BRO : 29.44 (unch)
Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.?

InvestorsObserver issues critical PriceWatch Alerts for ATOS, CRON, NBEV, TSRO, and XXII.

NBEV : 6.31 (-0.94%)
XXII : 2.39 (-2.05%)
ATOS : 1.44 (-4.64%)
TSRO : 74.96 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ATOS with:

Business Summary

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting...

See More

Key Turning Points

2nd Resistance Point 1.56
1st Resistance Point 1.50
Last Price 1.44
1st Support Level 1.40
2nd Support Level 1.36

See More

52-Week High 9.96
Fibonacci 61.8% 6.46
Fibonacci 50% 5.38
Fibonacci 38.2% 4.30
Last Price 1.44
52-Week Low 0.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar